# Case Report: Extracorporeal membrane oxygenation in acute coronary syndrome: a rare case of massive left ventricular thrombus

**Authors:** Jian Lan, Yifeng Mao, Chenyang Shi, Jian Ye, Qiang Zhong, Jingjing Li, Xijiang Zhang, Cheng Zheng

PMC · DOI: 10.3389/fcvm.2026.1778609 · Frontiers in Cardiovascular Medicine · 2026-03-16

## TL;DR

A 42-year-old man on VA-ECMO developed a massive heart blood clot despite anticoagulation, highlighting the risks and management challenges in such cases.

## Contribution

This case report highlights the rapid formation of a massive left ventricular thrombus in VA-ECMO patients and suggests improved anticoagulation and unloading strategies.

## Key findings

- A massive left ventricular thrombus formed within 14 hours despite therapeutic anticoagulation.
- The patient developed refractory multi-organ failure, leading to withdrawal of care.
- The case emphasizes the need for multimodal anticoagulation monitoring and advanced LV unloading strategies.

## Abstract

Left ventricular (LV) thrombus is a catastrophic complication during veno arterial-extracorporeal membrane oxygenation (VA-ECMO) support for cardiogenic shock, arising from a confluence of hemodynamic stasis, a prothrombotic state, and potential limitations of conventional anticoagulation monitoring.

A 42-year-old man with acute inferior-wall ST-elevation myocardial infarction developed refractory cardiogenic shock during percutaneous coronary intervention, necessitating VA-ECMO initiation. Dual antiplatelet therapy and systemic heparinization (targeting an activated partial thromboplastin time of 50–80 s) were maintained.

Despite therapeutic anticoagulation, serial echocardiography documented the formation of a massive LV thrombus occupying >90% of the cavity within a 14 h interval on the fourth day of ECMO support. The patient subsequently deteriorated into refractory multi-organ failure, leading to withdrawal of care.

This case underscores the rapidity and severity of LV thrombus formation in VA-ECMO patients with severe ventricular dysfunction. It highlights the critical need for proactive management, including multimodal anticoagulation monitoring and aggressive, individualized LV unloading strategies that may require escalation beyond intra-aortic balloon pump support to more direct decompression methods.

## Linked entities

- **Diseases:** cardiogenic shock (MONDO:0800175), multi-organ failure (MONDO:0043726)

## Full-text entities

- **Diseases:** myocardial infarction (MESH:D009203), multi-organ failure (MESH:D009102), LV thrombus (MESH:D013927), acute coronary syndrome (MESH:D054058), ventricular dysfunction (MESH:D018754), cardiogenic shock (MESH:D012770)
- **Chemicals:** VA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13034136/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13034136/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC13034136/full.md

---
Source: https://tomesphere.com/paper/PMC13034136